Rapid LC-MS/MS assay for the evaluation of hydroxyl radical generation and oxidative stress induction in vivo in rats;Tehnicǎ rapidǎ LC-MS/MS pentru evaluarea generǎrii de radicali hydroxyl şi a stresului oxidativ indus in vivo la şobolani

Revista Romana de Medicina de Laborator

Volumn 18, Issue 4, 2010, Pages 37-45

  Popa, Daniela Saveta ^a   Vlase, Laurian ^a   Chirilǎ, Daciana ^b   Loghin, Felicia ^a  

^a Faculty of Pharmacy

^b Faculty of Medicine

Author keywords

2; 3 DHBA; Hydroxyl radical; LC MS MS; Oxidative stress; Rat plasma

Indexed keywords

EID: 78651079573     PISSN: 18416624     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. López-Lázaro M. A New View of Carcinogenesis and an Alternative Approach to Cancer Therapy. Mol Med. 2010 Mar;16(3-4):144-53.
2. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA. Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis. Mediators Inflamm. 2010;2010:453892.
3. Nanayakkara PW, Gaillard CA. Vascular disease and chronic renal failure: new insights. Neth J Med. 2010 Jan;68(1):5-14.
4. Jellinger KA. Recent advances in our understanding of neurodegeneration. J Neural Transm. 2009 Sep;116(9):1111-62.
5. Dai DF, Rabinovitch PS. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med. 2009 Oct;19(7):213-20.
6. Awtry EH, Philippides GJ. Alcoholic and cocaine- associated cardiomyopathies. Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):289-99.
7. Saraçoglu A, Temel HE, Ergun B, Colak O. Oxidative stress-mediated myocardiotoxicity of ciprofloxacin and ofloxacin in juvenile rats. Drug Chem Toxicol. 2009;32(3):238-42.
8. de Zwart LL, Meerman JH, Commandeur JN, Vermeulen NP. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic Biol Med. 1999 Jan;26(1-2):202-26.
9. Tai C, Peng JF, Liu JF, Jiang GB, Zou H. Determination of hydroxyl radicals in advanced oxidation processes with dimethyl sulfoxide trapping and liquid chromatography. Analytica Chimica Acta. 2004;257:73-80.
10. Coudray C, Favier A. Determination of salicylate hydroxylation products as an in vivo oxidative stress marker. Free Radic Biol Med. 2000 Dec;29(11):1064-70.
11. Grootveld M, Halliwell B. Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Biochem. J. 1986 Jul; 237(2): 499-504.
12. Liu L, Leech JA, Urch RB, Silverman FS. In vivo salicylate hydroxylation: a potential biomarker for assessing acute ozone exposure and effects in humans. Am J Respir Crit Care Med. 1997 Nov;156(5):1405-12.
13. Yang ZJ, Xie Y, Bosco GM, Chen C, Camporesi EM. Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate release. Eur J Appl Physiol. 2010 Feb;108(3):513-22.
14. Obata T, Yonemoti H, Aomine M. The protective effect of fluvastatin on hydroxyl radical generation by inhibiting low-density lipoprotein (LDL) oxidation in the rat myocardium. Microvasc Res. 2009 Mar;77(2):163-5.
15. Luo X, Lehotay DC. Determination of hydroxyl radicals using salicylate as a trapping agent by gas chromatography- mass spectrometry. Clin Biochem. 1997 Feb;30(1):41-6.
16. Paterson JR, Blacklock C, Campbell G, Wiles D, Lawrence JR. The identification of salicylates as normal constituents of serum: a link between diet and health? J Clin Pathol. 1998 Jul;51(7):502-5.
17. Ren XR, Shao KS, Tang XY. Determination of salicylic acid and its hydroxylated products using high performance liquid chromatography and fluorescence detection. Se Pu. 2001 Mar;19(2):191-2.
18. Coudray C, Talla M, Martin S, Fatôme M, Favier A. High-performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as an in vivo marker of oxidative stress. Anal Biochem. 1995 May;227(1):101-11.
19. Tabatabaei AR, Abbott FS. LC/MS analysis of hydroxylation products of salicylate as an indicator of in vivo oxidative stress. Free Radic Biol Med. 1999 Apr;26(7-8):1054-8.
20. Guidance for Industry, Bioanalytical Method Validation. U.S. Department of Health and Human Services, Food and Drug Administration. Federal Register. 2001;66.
21. Guidance on the Investigation of Bioavailability and Bioequivalence. The European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products. 2001; CPMP/EWP/QWP/1401/98.
22. Imre S, Vlase L, Muntean DL, Bioanalytical method validation, Revista Romana de Medicina de Laborator. 2008; 10(1):13-21.
23. Vlase L, Imre S, Muntean D, Leucuta SE. Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detection. J. Pharm. Biomed. Anal., 2007 Jul;44(3):652-7.
24. Vlase L, Leucuta SE, Imre S. Determination of Tramadol and O-desmethyltramadol in human plasma by high-performance liquid chromatography with mass spectrometry detection. Talanta. 2008 May; 75(4):1104-9.